CHIRALITY IN DRUG DESIGN AND DEVELOPMENT
Covering every essential element in the development of chiral products, this reference provides a solid overview of the formulation, biopharmaceutical characteristics, and regulatory issues impacting the production of these pharmaceuticals. It supports researchers as they evaluate the pharmacodynami...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York
Marcel Dekker
2004
|
| Subjects: | |
| Online Access: | Click Here to View Status and Holdings. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag MARC
| LEADER | 00000nam a2200000#i 4501 | ||
|---|---|---|---|
| 001 | wils-311690 | ||
| 005 | 2021111411021 | ||
| 008 | 211214t2004 NYU ag# ##001 #deng#D | ||
| 020 | # | # | |a 0824750624 |q paperback |
| 040 | # | # | |a IUA |b eng |c IUA |d UiTM |e rda |
| 041 | 0 | # | |a eng |
| 090 | 0 | 0 | |a QV744 |b C551 2004 |
| 245 | 1 | 1 | |a CHIRALITY IN DRUG DESIGN AND DEVELOPMENT |c EDITED BY INDRA K. REDDY, REZA MEHVAR |
| 264 | # | 1 | |a New York |b Marcel Dekker |c 2004 |
| 264 | # | 4 | |c ©2004 |
| 300 | # | # | |a xii, 444 pages |b illustrations |c 24 cm |
| 336 | # | # | |a text |2 rdacontent |
| 337 | # | # | |a unmediated |2 rdamedia |
| 338 | # | # | |a volume |2 rdacarrier |
| 504 | # | # | |a Includes bibliographical references and index |
| 520 | # | # | |a Covering every essential element in the development of chiral products, this reference provides a solid overview of the formulation, biopharmaceutical characteristics, and regulatory issues impacting the production of these pharmaceuticals. It supports researchers as they evaluate the pharmacodynamic, pharmacokinetic, and toxicological characteristics of specific enantiomers and chiral drug compounds and addresses in one convenient reference all the major challenges pertaining to drug chirality that have been neglected in the literature. Chirality in Drug Design and Development collects the latest studies from an interdisciplinary team of experts on chiral drug design. |
| 650 | # | 0 | |a Chiral drugs |
| 650 | # | 0 | |a Drugs |x design |
| 650 | # | 0 | |a Drug development |
| 700 | 1 | # | |a Reddy, Indra K. |e edited |
| 700 | 1 | # | |a Mehvar, Reza |e edited |
| 856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=311690 |
| 998 | # | # | |a 00264#1a002.8.2||00264#1b002.8.4||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00520##a007.2||00520##b007.2|| |
New drug discovery and development